Alexion reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Alexion announced earnings per share of $2.71 on revenue of $1.38B. Analysts polled by anticipated EPS of $2.59 on revenue of $1.31B. That with comparison to EPS of $2.14 on revenue of $1.13B in the same period a year before. Alexion had reported EPS of $2.79 on revenue of $1.26B in the previous quarter. Analysts are expecting EPS of $2.71 and revenue of $1.34B in the upcoming quarter.
Alexion shares are down 1.12% from the beginning of the year and are trading at $106.94 , still down 24.62% from its 52 week high of $141.86 set on April 10, 2019. They are under-performing the S&P 500 which is up 0.87% year to date.
Alexion follows other major Healthcare sector earnings this month
Alexion's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Novartis ADR had beat expectations on Wednesday with fourth quarter EPS of $1.32 on revenue of $12.4B, compared to forecast for EPS of $1.31 on revenue of $12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
